Biotech

All Articles

A nearer consider Intense Biotech's Strong 15

.Within this week's episode of "The Best Line," our company're diving into Strong Biotech's annual F...

Lilly experiences phase 2 breakdown of tau-targeting med

.The confetti is actually still soaring coming from Eli Lilly's gathering celebrating the approval o...

Biogen CMO Maha Radhakrishnan participates in Sofinnova-- Chutes &amp Ladders

.Invite to today's Chutes &amp Ladders, our summary of considerable leadership hirings, shootings as...

Lykos will ask FDA to reassess its choice observing rejection of MDMA treatment for post-traumatic stress disorder

.Complying with an inadequate revealing for Lykos Therapeutics' MDMA prospect for trauma at a latest...

AN 2 fifty percents census, ceases stage 3 trial after records let down

.AN2 Therapeutics is actually reviewing its organization in response to poor midphase data, promisin...

Merck pays $700M for bispecific, snooping autoimmune position and possibility to challenge Amgen in cancer

.Merck &amp Co. is paying for $700 million ahead of time to test Amgen in a blood cancer market. The...

Gilead spends J&ampJ $320M to exit licensing offer for seladelpar

.Along With Gilead Sciences about to an FDA choice for its liver illness drug seladelpar, the provid...

' All hands on deck' at Lilly as peers target excessive weight market

.CEO David Ricks can easily view the firms establishing camping tents at basecamp behind Eli Lilly i...

Entero laying off staff, vacating office and also pausing R&ampD

.Mattress Liquidators has actually transformed Entero Rehabs white colored as a sheet. The financial...

Exelixis goes down ADC after deciding it is actually no match for Tivdak

.Exelixis is surrendering on its cells factor (TF)- targeting antibody-drug conjugate after wrapping...